Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
SOHU$13.20+0.40(+3.12%)Sohu.com to Report Third Quarter 2026 Financial Results on November 9, 2026 Sohu.com Limited (NASDAQ: SOHU), a leading Chinese online media platform and game business group, will report its third quarter 2026 unaudited...[1:00:00 AM ET]

LGND · NASDAQ

Ligand Pharmaceuticals Incorporated

$317.86 -3.87 (-1.21%)

Company overview

Ligand Pharmaceuticals Incorporated is a biopharmaceutical company that focuses on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela for treating multiple myeloma; Veklury for treating moderate or severe COVID-19; teriparatide injection for osteoporosis; Vaxneuvance for preventing invasive disease caused by Streptococcus pneumoniae; and Pneumosil, a pneumococcal conjugate vaccine to help fight pneumococcal pneumonia in children. The company also offers Rylaze, a recombinant erwinia asparaginase for treating acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; Nexterone, a Captisol-enabled formulation of amiodarone; and Zulresso, a Captisol-enabled formulation of brexanolone for treating postpartum depression.

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Market cap
$6.3B
Employees
68
Headquarters
Jupiter, CA
Website
ligand.com
CEO
Todd C. Davis
Listed
November 18, 1992
P/E
40.54
Dividend yield
5.35%

Company financials

Revenue
$274M
Gross profit
$271M
Operating income
$101M
EBITDA
$254M
Net income
$154M
EPS
$7.84
Total assets
$1.5B
Total debt
$452M
Gross margin
98.61%
Net margin
55.95%
Earnings yield
2.47%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

No geographic segmentation.

Showing FY 2025

Price chart

194.95229.13263.32297.51331.69
LGND 1D NASDAQ O321.23H323.47L309.63C314.91-3.87 (-1.21%)Vol104.50K

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
Ticker Type Headline Source Published
LGNDLigand Pharmaceuticals Incorporated Stock news Ligand Pharmaceuticals Incorporated (LGND) Q3 2026 Earnings Call Transcript Seeking Alpha
LGNDLigand Pharmaceuticals Incorporated Stock news What Ligand Pharmaceuticals (LGND) Said on Its Q3 Earnings Call MarketBeat
LGNDLigand Pharmaceuticals Incorporated Press release Ligand Reports Third Quarter 2026 Financial Results GlobeNewswire
LGNDLigand Pharmaceuticals Incorporated Press release Ligand to Participate in November Investor Conferences GlobeNewswire
LGNDLigand Pharmaceuticals Incorporated Press release Ligand to Host Investor Day on December 8, 2026 GlobeNewswire
LGNDLigand Pharmaceuticals Incorporated Press release Ligand to Report Third Quarter 2026 Financial Results on October 29, 2026 GlobeNewswire
LGNDLigand Pharmaceuticals Incorporated Press release Ligand and AvenCell Therapeutics Enter Financing Agreement to Advance Pipeline of Next-Generation CAR-T Therapies for Up to $47 Million GlobeNewsWire
LGNDLigand Pharmaceuticals Incorporated Press release Primrose Bio® Raises Significant Growth Capital Investment Led by Signet Healthcare Partners PRNewsWire
LGNDLigand Pharmaceuticals Incorporated Press release Ligand Acquires Royalty and Milestone Interest in Santen's Ryjunea® from Sydnexis for $23 Million GlobeNewsWire
LGNDLigand Pharmaceuticals Incorporated Stock news Ligand Pharmaceuticals: Owning It Gives You A Stake Across Biotech Seeking Alpha
LGNDLigand Pharmaceuticals Incorporated Press release Ligand to Participate in September Investor Conferences GlobeNewsWire
LGNDLigand Pharmaceuticals Incorporated Stock news Ligand Pharmaceuticals Q2 Earnings Call Highlights MarketBeat
LGNDLigand Pharmaceuticals Incorporated Stock news Ligand Pharmaceuticals Incorporated (LGND) Q2 2026 Earnings Call Transcript Seeking Alpha
LGNDLigand Pharmaceuticals Incorporated Stock news Ligand Pharmaceuticals Incorporated $LGND Shares Sold by Arrowstreet Capital Limited Partnership Defense World
LGNDLigand Pharmaceuticals Incorporated Press release Ligand to Report Second Quarter 2026 Financial Results on August 6, 2026 GlobeNewsWire
LGNDLigand Pharmaceuticals Incorporated Press release Ligand Completes Acquisition of XOMA Royalty, Creating a Portfolio of More than 200 Biopharmaceutical Royalty Assets GlobeNewsWire
LGNDLigand Pharmaceuticals Incorporated Press release XOMA Royalty Announces Closing of Its Acquisition by Ligand GlobeNewsWire
LGNDLigand Pharmaceuticals Incorporated Stock news 5 Stock Setups Where Wall Street Sees the Most Upside Right Now 247 Wallst
LGNDLigand Pharmaceuticals Incorporated Stock news CRISPR Therapeutics vs. Viking Therapeutics: Is a Gene-Editing or Weight Loss Focused Stock Is a Better Buy in 2026? The Motley Fool
LGNDLigand Pharmaceuticals Incorporated Press release Ligand to Participate in June Investor Conferences GlobeNewsWire
See more
FAQ

Questions about Ligand Pharmaceuticals Incorporated

What does Ligand Pharmaceuticals Incorporated do?
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company that focuses on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela for treating multiple myeloma; Veklury for treating moderate or severe COVID-19; teriparatide injection for osteoporosis; Vaxneuvance for preventing invasive disease caused by Streptococcus pneumoniae; and Pneumosil, a pneumococcal conjugate vaccine to help fight pneumococcal pneumonia in children. The company also offers Rylaze, a recombinant erwinia asparaginase for treating acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; Nexterone, a Captisol-enabled formulation of amiodarone; and Zulresso, a Captisol-enabled formulation of brexanolone for treating postpartum depression.
What is LGND's market cap?
Ligand Pharmaceuticals Incorporated (LGND) is a listed stock with a live quote. The latest market cap on this page is $6.3B.
Where is Ligand Pharmaceuticals Incorporated headquartered?
Ligand Pharmaceuticals Incorporated is headquartered in Jupiter, CA.
How do I get LGND news from the API?
Call GET /v1/news?tickers=LGND. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does LGND news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for LGND, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the LGND price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 1,000 REST requests a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs